Labcorp launches companion diagnostic for ovarian cancer treatment
Tweet Send to a Friend
Labcorp (NYSE: LH) announced the nationwide availability of Agilent Technologies' PD-L1 IHC 22C3 pharmDx, a companion diagnostic approved by the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


